Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2026 ,inter alia, to consider and approve matters related to Annual General Meeting and any other business as the board deems fit to discuss with the permission of the chairman.
Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 24 2026
Filed with BSE · · 1 page · English
Summary by 6ix AI
Venmax Drugs & Pharmaceuticals Ltd. has announced a Board Meeting scheduled for the end of August to discuss several important agenda items. The meeting will cover the approval of the notice for the upcoming Annual General Meeting and the company's annual report for the previous financial year. Additionally, the Board will decide on the appointment of a scrutinizer and e-voting agency for the Annual General Meeting. This filing serves as a formal notification to the stock exchange regarding the upcoming Board Meeting and its agenda.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 08 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 07 2026
- Statement Of Deviation & Variation
- Unaudited Financial Results For The Quarter Ended June 30, 2026.
Later from Venmax Drugs & Pharmaceuticals
- Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 31 2026
- Reg. 34 (1) Annual Report.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 01 2026
- Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals